Hypertension in thoracic transplant recipients
نویسندگان
چکیده
منابع مشابه
PREGNANCY IN RENAL TRANSPLANT RECIPIENTS
ABSTRACT Background: Correction of the uremic state by a functioning allograft often restores fertility in women of reproductive age. The rate of fertility significantly differs between industrial countries, developing and middle east countries. On the other hand the results of pregnancy in Kidney Transplantation (KTP) patients are significantly better than hemodialysis patients, and pregnancy...
متن کاملSystemic hypertension in heart transplant recipients.
Heart transplant recipients develop systemic hypertension (SH), which is generally difficult to clinically control, requiring the use of several antihypertensive drugs. The pathophysiology involves the action of cyclosporine through the following mechanisms: alterations in the renin-angiotensin-aldosterone and sympathetic system, in prostaglandin and thromboxane A2 levels, in plasmatic endothel...
متن کاملMalignant skin lesions in transplant recipients
Several advances in the filed of organ transplantation in last decades have resulted in significant increase in the number and methods of transplantation. In this article various aspects of organ transplantation including immunosuppressive medications, common skin tumors seen in transplant recipients, possible mechanisms involved in increased incidence of skin tumors and finally preventive meas...
متن کاملCiclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.
BACKGROUND AND OBJECTIVES Therapeutic drug monitoring of ciclosporin has been recognized as an essential tool in the management of allograft transplant recipients, as it could help improve their outcome. However, there is still no consensus about the optimal method for monitoring ciclosporin after thoracic transplantation. Better knowledge of the pharmacokinetics of ciclosporin in thoracic tran...
متن کاملHypertension in heart transplant recipients: more than just cyclosporine.
Cardiac transplantation offers definitive therapy for selected patients with end-stage heart failure and thus provides significant improvements in survival in these recipients. Heart transplantation comes with a cost, however, resulting from the actual transplantation procedure, the subsequent allo-immune response to the transplant and the immunosuppressive medications required to keep the allo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Human Hypertension
سال: 1998
ISSN: 0950-9240,1476-5527
DOI: 10.1038/sj.jhh.1000710